GANX
GANX
NASDAQ · Biotechnology

Gain Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.75
+0.13 (+8.02%)
As of Feb 8, 2:16 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +1,617.1% upside
Low Target $22.12
Average Target $30.05
High Target $38.96
Current Price $1.75
Current
$1.75
Target
$30.05
$22.12 $30.05 avg $38.96
Scenario Analysis
Bear Case
$22.12
1,164.0%
Low target
Base Case
$30.05
+1,617.1%
Avg target
Bull Case
$38.96
+2,126.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$38.77
-95.5% from high
52-Week Low
$17.44
+-90.0% from low
Target vs 52W High
$30.05
-22.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%